drugset / Trial / NCT05728424
One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL
RandomizedParallel-groupQuadruple-blindTreatment
Summary
1. To assess the efficacy of the duration of Vonoprazan based triple regimen (one versus two weeks), in the eradication of H-pylori among patients attending gastroenterology clinics of Karachi, Pakistan. 2. To assess the improvement in the quality of life of patients receiving Vonoprazan as part of the triple regimen.
Timeline
- Start
- 2022-09-20
- Primary completion
- 2023-04-01
- Completion
- 2023-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1 g | — |
| Comparator | Levofloxacin | Small molecule | 500 mg | — |
| Comparator | Vonoprazan | Other / unclassified | 20 mg | — |